Establishes the Sickle Cell Treatment Act

This bill establishes the "Sickle Cell Treatment Act" to improve care for sickle cell disease patients in New York. It designates five "centers for excellence" (with two north of Putnam/Orange counties) and ten outpatient treatment centers based on patient populations, providing each center with annual funding ($500,000 for excellence centers, $250,000 for outpatient centers) to support specialized care, research, and equipment. The bill also modifies opioid prescribing rules to exempt sickle cell disease patients from a three-month opioid limit, ensuring they can receive necessary pain management without restrictive barriers. These changes directly affect hospitals designated as centers, sickle cell patients requiring specialized care, and healthcare providers managing chronic pain.